Format

Send to

Choose Destination
PLoS One. 2015 Nov 12;10(11):e0142545. doi: 10.1371/journal.pone.0142545. eCollection 2015.

Triploidy--Observations in 154 Diandric Cases.

Author information

1
Department of Biomedicine, Aarhus University, Aarhus, Denmark.
2
Beijing Genomics Institute/HuaDa-Shenzhen, Shenzhen, China.
3
Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
4
Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark.
5
Institute of Pathology, Aalborg University Hospital, Aalborg, Denmark.
6
Department of Gynecology and Obstetrics, Aarhus University Hospital, Aarhus, Denmark.
7
Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.

Abstract

Hydatidiform moles (HMs) are abnormal human pregnancies with vesicular chorionic villi, imposing two clinical challenges; miscarriage and a risk of gestational trophoblastic neoplasia (GTN). The parental type of most HMs are either diandric diploid (PP) or diandric triploid (PPM). We consecutively collected 154 triploid or near-triploid samples from conceptuses with vesicular chorionic villi. We used analysis of DNA markers and/or methylation sensitive-MLPA and collected data from registries and patients records. We performed whole genome SNP analysis of one case of twinning (PP+PM).In all 154 triploids or near-triploids we found two different paternal contributions to the genome (P1P2M). The ratios between the sex chromosomal constitutions XXX, XXY, and XYY were 5.7: 6.9: 1.0. No cases of GTN were observed. Our results corroborate that all triploid human conceptuses with vesicular chorionic villi have the parental type P1P2M. The sex chromosomal ratios suggest approximately equal frequencies of meiosis I and meiosis II errors with selection against the XYY conceptuses or a combination of dispermy, non-disjunction in meiosis I and meiosis II and selection against XYY conceptuses. Although single cases of GTN after a triploid HM have been reported, the results of this study combined with data from previous prospective studies estimate the risk of GTN after a triploid mole to 0% (95% CI: 0-1,4%).

PMID:
26562155
PMCID:
PMC4642992
DOI:
10.1371/journal.pone.0142545
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center